Translational Session
Novel Strategies for Preventing End-Organ Damage and Dysfunction from CKD-MBD, Including the Jack W. Coburn, MD, Endowed Lectureship
November 04, 2022 | 02:00 PM - 04:00 PM
Location: W414, Orange County Convention Center, West Building
Session Description
This session highlights recent discoveries about the contribution of CKD-MBD to organ pathology and dysfunction and examines current evidence for strategies to prevent these adverse outcomes.
ASN gratefully acknowledges Amgen for support of the Jack W. Coburn, MD, Endowed Lectureship.
Learning Objective(s)
- Define the evidence for phosphate as a driver of kidney injury
- Outline novel therapeutic targets for the prevention of vascular calcification
- Discuss novel strategies for the prevention and management of CKD-MBD
- Describe the relationship between mineral metabolism abnormalities, inflammation, and anemia in CKD
Learning Pathway(s)
- Bones, Stones, and Mineral Metabolism
- CKD Non-Dialysis
Moderators
- Valentin David, MS, PhD
- Jessica B. Kendrick, MD, MPH
Presentations
- A Tangled Web: Complex Relationship Between CKD-MBD, Inflammation, and Anemia
02:00 PM - 02:30 PM
Jodie L. Babitt, MD
- Contribution of Urinary Phosphate to CKD Progression
02:30 PM - 03:00 PM
Kyle Jansson, MD, PhD
- Novel Strategies for the Prevention of Vascular Calcification in CKD
03:00 PM - 03:30 PM
Demetrios Braddock, MD, PhD
- Systems Biology Approach to the Management of CKD-MBD: The Jack W. Coburn, MD, Endowed Lectureship
03:30 PM - 04:00 PM
Eleanor D. Lederer, MD, FASN
